USE OF RHO GTPASE ACTIVATING TOXINES FOR THE TREATMENT AND/OR PREVENTION OF SYMPTOMATOLOGY ASSOCIATED WITH RETT SYNDROME

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP11713878.4

公开号：

EP2536424A2

申请日:

2011.02.15

申请国别(地区):

EP

年份:

2012

代理人:

摘要：

The invention concerns the use of a toxin selected from the group consisting of: type 1 (CNF1 ), type 2 (CNF2) or type 3 (CNF3) Cytotoxic Necrotizing Factor from Escherichia coli or CNFY from Yersinia spp. or DNT from Bordetella spp, active fragments or mixtures thereof for the preparation of a medicament for the treatment and/or prevention of symptomatology associated with Rett syndrome (RTT).

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/